MariMed (MRMD) Stock Analysis & Winston Score
MariMed Inc. is a cannabis company that grows, processes, and sells marijuana products in the United States. Its products include flower, edibles, concentrates, and vapes sold under brands like Betty's Eddies and Bubby's Baked. It sells to adult recreational users and medical patients through its own dispensaries and licensed partners. MariMed makes money by selling cannabis products directly to consumers through retail dispensaries and by licensing its brands and operations to other cannabis businesses. The company operates in a handful of states where cannabis is legal, including Illinois, Maryland, and Massachusetts. Its multi-state presence and owned brands give it some competitive footing, but the cannabis industry faces heavy regulation, high taxes, and ongoing competition from illegal markets. The biggest risk is that federal cannabis laws in the U.S. have not changed, which limits banking access, raises costs, and keeps institutional investors on the sidelines.
Winston Score: 21/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (7/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (1/10)
- Stability: Weak (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.07
Market Cap: $26M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

